zileuton has been researched along with pyrrolidino-benzylphenoxyethanamine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askonas, LJ; Chandrakumar, NS; Chen, BB; Chen, HY; Corley, DG; Desai, BN; Djuric, SW; Docter, SH; Durley, RC; Gasiecki, AF; Gierse, JK; Haack, RA; Harding, EI; Highkin, MK; Kachur, JF; Kilpatrick, BF; Kim, SH; Krivi, GG; Miyashiro, JM; Parnas, BL; Penning, TD; Pyla, EY; Russell, MA; Smith, WG; Villani-Price, D; Yu, SS | 1 |
1 other study(ies) available for zileuton and pyrrolidino-benzylphenoxyethanamine
| Article | Year |
|---|---|
Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolase.
Topics: Administration, Oral; Animals; Enzyme Inhibitors; Epoxide Hydrolases; Humans; In Vitro Techniques; Leukotriene B4; Male; Mice; Pyrrolidines; Structure-Activity Relationship | 2000 |